MARKET

TBPH

TBPH

Theravance Bioph
NASDAQ
15.08
-0.11
-0.72%
After Hours: 15.10 +0.02 +0.13% 18:08 03/27 EDT
OPEN
15.09
PREV CLOSE
15.19
HIGH
15.25
LOW
14.86
VOLUME
574.15K
TURNOVER
--
52 WEEK HIGH
21.03
52 WEEK LOW
7.90
MARKET CAP
776.51M
P/E (TTM)
7.33
1D
5D
1M
3M
1Y
5Y
1D
Theravance Biopharma Price Target Raised to $15.00/Share From $13.00 by TD Cowen
Dow Jones · 5d ago
Theravance Biopharma Is Maintained at Hold by TD Cowen
Dow Jones · 5d ago
TD Cowen Maintains Hold on Theravance Biopharma, Raises Price Target to $15
Benzinga · 5d ago
Theravance Biopharma price target raised to $15 from $13 at TD Cowen
TipRanks · 5d ago
Weekly Report: what happened at TBPH last week (0316-0320)?
Weekly Report · 5d ago
Theravance Biopharma: Post‑CYPRESS Restructuring Leaves Limited Upside and Justifies Neutral Stance
TipRanks · 5d ago
Theravance Biopharma Price Target Maintained With a $21.00/Share by BTIG
Dow Jones · 03/20 10:30
BTIG Reiterates Buy on Theravance Biopharma, Maintains $21 Price Target
Benzinga · 03/20 10:20
More
About TBPH
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development and commercialization of medicines for the specialty respiratory and neurologic diseases. The Company operates through a single segment, namely, development and commercialization of human therapeutics. Its product, YUPELRI (revefenacin) inhalation solution, is a nebulized long-acting muscarinic antagonist used for the treatment of patients with chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps the muscles around the airway in the lungs stay relaxed to prevent symptoms, such as wheezing, shortness of breath, and others. Its Ampreloxetine, is a late-stage investigational norepinephrine reuptake inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension in patients with Multiple System Atrophy.

Webull offers Theravance Biopharma Inc stock information, including NASDAQ: TBPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TBPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TBPH stock methods without spending real money on the virtual paper trading platform.